RESUMEN
The oomycete Phytophthora melonis causes a severe disease in cucumber plants in Asia. In this study, the diameter of cucumber hypocotyl in the resistant variety 'Shantou qing gua' was significantly larger than that of the susceptible variety 'Zhongnong No. 20'. The significantly lower incidence of disease and less invasive hyphae on the epidermis and transverse section of hypocotyls in P plants of the resistant variety than those in susceptible cultivars were also observed. Brassinosteroids are a class of phytohormones that affect plant growth and development and are involved in regulating plant resistance to a variety of biotic and abiotic stresses. 24-Epibrassinolide root drenching significantly enhanced the thickening of cucumber hypocotyl. Thick hypocotyls showed strong resistance to P. melonis, indicating that it significantly reduced the incidence of disease and retarded the hyphae extension for both resistant and susceptible cucumbers. 24-Epibrassinolide pretreatment had no significant effect on the elongation of cucumber hypocotyl. Further histological observation showed that under the condition of infection with P. melonis, exogenous 24-epibrassinolide could induce lignin deposition in external phloem and xylem vessel cell wall of the cucumber hypocotyl vascular bundle. There is also an accumulation of callose in the external phloem sieve plate, which activates the resistance responses in cell walls. It is worth mentioning that in both inoculated and uninoculated conditions, exogenous 24-epibrassinolide enhanced lignin formation in external phloem and xylem vessel cell wall of the vascular bundle. This increased the content of lignin in hypocotyl as well as the number of vascular bundles in the hypocotyl base. The above results show that 24-epibrassinolide constitutively regulates the thickening of cucumber hypocotyl and the development of vascular bundle, hence preventing phytophthora infection and inducing plant resistance to disease.
Asunto(s)
Brasinoesteroides/uso terapéutico , Cucumis sativus/química , Phytophthora/patogenicidad , Esteroides Heterocíclicos/uso terapéuticoRESUMEN
Steroids are a pivotal class of hormones with a key role in growth modulation and signal transduction in multicellular organisms. Synthetic steroids are widely used to cure large array of viral, fungal, bacterial, and cancerous infections. Brassinosteroids (BRs) are a natural collection of phytosterols, which have structural similarity with animal steroids. BRs are dispersed universally throughout the plant kingdom. These plant steroids are well known to modulate a plethora of physiological responses in plants leading to improvement in quality as well as yield of food crops. Moreover, they have been found to play imperative role in stress-fortification against various stresses in plants. Over a decade, BRs have conquered worldwide interest due to their diverse biological activities in animal systems. Recent studies have indicated anticancerous, antiangiogenic, antiviral, antigenotoxic, antifungal, and antibacterial bioactivities of BRs in the animal test systems. BRs inhibit replication of viruses and induce cytotoxic effects on cancerous cell lines. Keeping in view the biological activities of BRs, this review is an attempt to update the information about prospects of BRs in biomedical and clinical application.
Asunto(s)
Investigación Biomédica , Brasinoesteroides/farmacología , Animales , Brasinoesteroides/análisis , Brasinoesteroides/uso terapéutico , Dieta , HumanosRESUMEN
The prevalence of obesity is increasing globally, and obesity is a major risk factor for metabolic diseases such as type 2 diabetes. Previously, we reported that oral administration of homobrassinolide (HB) to healthy rats triggered a selective anabolic response that was associated with lower blood glucose. Therefore, the aim of this study was to evaluate the effects of HB administration on glucose metabolism, insulin sensitivity, body composition, and gluconeogenic gene expression profiles in liver of C57BL/6J high-fat diet-induced obese mice. Acute oral administration of 50-300 mg/kg HB to obese mice resulted in a dose-dependent decrease in fasting blood glucose within 3 h of treatment. Daily chronic administration of HB (50 mg/kg for 8 wk) ameliorated hyperglycemia and improved oral glucose tolerance associated with obesity without significantly affecting body weight or body composition. These changes were accompanied by lower expression of two key gluconeogenic enzymes, phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G-6-Pase), and increased phosphorylation of AMP-activated protein kinase in the liver and muscle tissue. In vitro, HB treatment (1-15 µM) inhibited cyclic AMP-stimulated but not dexamethasone-stimulated upregulation of PEPCK and G-6-Pase mRNA levels in H4IIE rat hepatoma cells. Among a series of brassinosteroid analogs related to HB, only homocastasterone decreased glucose production in cell culture significantly. These results indicate the antidiabetic effects of brassinosteroids and begin to elucidate their putative cellular targets both in vitro and in vivo.
Asunto(s)
Brasinoesteroides/uso terapéutico , Suplementos Dietéticos , Hipoglucemiantes/uso terapéutico , Obesidad/dietoterapia , Proteínas Quinasas Activadas por AMP/metabolismo , Animales , Brasinoesteroides/administración & dosificación , Línea Celular , AMP Cíclico/antagonistas & inhibidores , AMP Cíclico/metabolismo , Dieta Alta en Grasa/efectos adversos , Regulación de la Expresión Génica , Glucosa-6-Fosfatasa/genética , Glucosa-6-Fosfatasa/metabolismo , Hiperglucemia/prevención & control , Resistencia a la Insulina , Hígado/enzimología , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/sangre , Obesidad/etiología , Fosfoenolpiruvato Carboxiquinasa (ATP)/genética , Fosfoenolpiruvato Carboxiquinasa (ATP)/metabolismo , Fosforilación , Procesamiento Proteico-Postraduccional , ARN Mensajero/metabolismo , Distribución AleatoriaRESUMEN
We have demonstrated previously that the brassinosteroid (BR) 24-epibrassinolide exerts neuroprotective effects deriving from its antioxidative properties. In this study, we synthesized 2 natural BRs and 5 synthetic analogs and analyzed their neuroprotective actions in neuronal PC12 cells, against 1-methyl-4-phenylpyridinium (MPP(+)), a neurotoxin known to induce oxidative stress and degenerescence of dopaminergic neurons characteristic of Parkinsonian brains. We also tested the neuroprotective potential of 2 commercially available BRs. Our results disclosed that 6 of the 9 BRs and analogs tested protected neuronal PC12 cells against MPP(+) toxicity. In addition, our structure-activity study suggests that the steroid B-ring and lateral chain play an important role for their neuroprotective action.